BPMX
BioPharmX Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA.
Market Cap: 9.32 Million
Primary Exchange: NYSE American
Website: http://www.biopharmx.com
Shares Outstanding: 18.3 Million
Float: 16 Million
Dividend: (%)
Beta: 0.8890557149517132
Sector: Producer Manufacturing
Industry: Miscellaneous Manufacturing
Ethical Flags
Longest drawdown: 1263 trading days
From: 2015-06-11 To: 2020-05-18
Lowest Point:
BioPharmX EPS misses by $0.10
via: SeekingAlpha at 2019-06-11 12:13:27:000
BioPharmX (NYSEMKT: BPMX ): Q1 Non-GAAP EPS of -$0.36; GAAP EPS of -$0.38 misses by $0.10 . More news on: BioPharmX Corporation, Earnings news and commentary, , Read more … read more...
BioPharmX EPS misses by $0.10
via: SeekingAlpha at 2019-06-11 12:13:27:000
BioPharmX (NYSEMKT: BPMX ): Q1 Non-GAAP EPS of -$0.36; GAAP EPS of -$0.38 misses by $0.10 . More news on: BioPharmX Corporation, Earnings news and commentary, , Read more … read more...
BioPharmX EPS misses by $0.10
via: SeekingAlpha at 2019-06-11 12:13:27:000
BioPharmX (NYSEMKT: BPMX ): Q1 Non-GAAP EPS of -$0.36; GAAP EPS of -$0.38 misses by $0.10 . More news on: BioPharmX Corporation, Earnings news and commentary, , Read more … read more...
BioPharmX Reports Fiscal First Quarter 2020 Financial Results
via: PR Newswire at 2019-06-11 12:10:00:000
SAN JOSE, Calif. , June 11, 2019 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the quarter endedApril 30, 2019. Recent… read more...
BioPharmX Reports Fiscal First Quarter 2020 Financial Results
via: PR Newswire at 2019-06-11 12:10:00:000
SAN JOSE, Calif. , June 11, 2019 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the quarter endedApril 30, 2019. Recent… read more...
BioPharmX Reports Fiscal First Quarter 2020 Financial Results
via: PR Newswire at 2019-06-11 12:10:00:000
SAN JOSE, Calif. , June 11, 2019 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the quarter endedApril 30, 2019. Recent… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|